PETMED EXPRESS INC

Listed Company

PETSCIK 0001040130NasdaqAcceleratedRetail-Drug Stores And Proprietary StoresFloridaGBFY ends Mar 31

Period

FY 2026

Revenue

$179.02M

Net Income

$-57.29M

Total Assets

$81.19M

Equity

$28.94M

Shares Out

21.37M

Op. Cash Flow

$-28.39M

Business

PETMED EXPRESS INC is a direct-to-consumer pet health and wellness retailer that operates a consumer-first digital platform delivering prescription and non-prescription pet products. The company offers branded and generic pharmaceuticals, compounded prescriptions, pharmacy fulfillment, prescription and non-prescription foods, supplements, treats, private-label products, telemedicine and customer support services. Its operations include in-house pharmacies and fulfillment centers, a customer contact center, and partnerships (including PetCareRx and telehealth partners) as core business divisions. It sells primarily across the United States through e-commerce sites, mobile apps, a toll-free contact center and brokered employer benefit channels.

Summary from filing dated 2025-10-14

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	Mar 31, 2026 2026-03-31	Mar 31, 2025 2025-03-31	Mar 31, 2024 2024-03-31
Net sales	179	227	274
Cost of sales	127	158	189
Inventory write-down	2	0	0
Gross profit	50	69	85
Operating expenses:	—	—	—
General and administrative	51	39	55
Advertising	22	24	31
Depreciation and amortization	9	7	7
Impairment of goodwill and intangible assets	27	1	0
Total operating expenses	109	71	93
Loss from operations	−59	−2	−8
Other income:	—	—	—
Interest income (expense), net	511,000	185,000	511,000
Other, net	803,000	758,000	1
Total other income (expense)	1	943,000	2
(Loss) income before provision for income taxes	−57	−587,000	−6
(Benefit) provision for income taxes	−73,000	6	1
Net loss	−57	−6	−7
Net loss per common share:	—	—	—
Basic (in dollars per share)	−2.74	−0.3	−0.37
Diluted (in dollars per share)	−2.74	−0.3	−0.37
Weighted average number of common shares outstanding:	—	—	—
Basic (in shares)	21	21	20
Diluted (in shares)	21	21	20
Cash dividends declared per common share (in dollars per share)	0	0	0.6

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	Mar 31, 2026 2026-03-31	Mar 31, 2025 2025-03-31
ASSETS	—	—
Current assets:	—	—
Cash and cash equivalents	21	55
Accounts receivable, less allowance for credit losses of $25 and $91, respectively	2	2
Inventories, net	14	16
Prepaid expenses and other current assets	6	5
Prepaid income taxes	258,000	299,000
Total current assets	44	79
Noncurrent assets:	—	—
Property and equipment, net	26	29
Intangible and other assets, net	11	13
Goodwill	0	27
Operating lease right-of-use assets, net	512,000	966,000
Total noncurrent assets	38	70
Total assets	81	149
LIABILITIES AND SHAREHOLDERS' EQUITY	—	—
Current liabilities:	—	—
Accounts payable	21	24
Sales tax payable	22	25
Accrued expenses and other current liabilities	8	12
Current operating lease liabilities	493,000	461,000
Deferred revenue	689,000	2
Income taxes payable	20,000	80,000
Total current liabilities	52	63
Deferred tax liabilities, net	175,000	263,000
Long-term operating lease liabilities	42,000	535,000
Total liabilities	52	64
Commitments and contingencies (Note 14)	—	—
Shareholders' equity:	—	—
Preferred stock	9,000	9,000
Common stock, $.001 par value, 40,000,000 shares authorized; 21,385,638 and 20,656,822 shares issued and outstanding, respectively	21,000	21,000
Additional paid-in capital	20	19
Retained earnings	9	67
Total shareholders' equity	29	85
Total liabilities and shareholders' equity	81	149

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	Mar 31, 2026 2026-03-31	Mar 31, 2025 2025-03-31	Mar 31, 2024 2024-03-31
Cash flows from operating activities:	—	—	—
Net loss	−57	−6	−7
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:	—	—	—
Depreciation and amortization	9	7	7
Impairment of goodwill and intangible assets	27	1	0
Inventory write-down	2	0	0
Share based compensation, net	1	−7	7
Deferred income taxes	−88,000	5	292,000
Bad debt (recovery) expense	−36,000	365,000	324,000
Change in sales tax liability estimation	−3	0	0
(Increase) decrease in operating assets and increase (decrease) in liabilities:	—	—	—
Accounts receivable	−445,000	−601,000	2
Inventories	−471,000	−12	6
Prepaid income taxes	−41,000	111,000	−675,000
Prepaid expenses and other current assets	1	−995,000	185,000
Operating lease right-of-use assets, net	−454,000	−466,000	−788,000
Accounts payable	−3	−13	6
Sales tax payable	122,000	−145,000	−1
Accrued expenses and other current liabilities	−4	4	276,000
Operating lease liabilities	−461,000	−458,000	−766,000
Deferred revenue	−1	−518,000	−390,000
Income taxes payable	−60,000	80,000	0
Net cash (used in) provided by operating activities	−28	5	4
Cash flows from investing activities:	—	—	—
Purchase of minority interest investment in Vetster	0	0	300,000
Acquisition of PetCareRx, net of cash acquired	0	0	36
Purchases of property and equipment	5	5	5
Net cash used in investing activities	−5	−5	−41
Cash flows from financing activities:	—	—	—
Dividends paid	21,000	181,000	12
Cash paid for tax withholding on net settlement of restricted stock	278,000	0	0
Net cash used in financing activities	−299,000	−181,000	−12
Net decrease in cash and cash equivalents	−33	−576,000	−49
Cash and cash equivalents, at end of fiscal year	—	—	—
Cash and cash equivalents, at end of fiscal year	—	—	—
Supplemental disclosure of cash flow information:	—	—	—
Cash paid for income taxes	52,000	525,000	130,000
Dividends payable in accrued expenses	0	26,000	1
Non-cash investing activity for property and equipment additions	282,000	2	0

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro